-
Je něco špatně v tomto záznamu ?
Lithium rescues cultured rat metatarsals from dexamethasone-induced growth failure
O. Soucek, O. Cinek, L. Velentza, V. Semjonov, M. Bezdicka, F. Zaman, L. Sävendahl
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 1967 do Před 1 rokem
ProQuest Central
od 2016-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2016-01-01 do Před 1 rokem
Public Health Database (ProQuest)
od 2016-01-01 do Před 1 rokem
- MeSH
- beta-katenin * metabolismus MeSH
- chlorid lithný * farmakologie MeSH
- dexamethason * farmakologie MeSH
- glukokortikoidy farmakologie MeSH
- krysa rodu rattus MeSH
- lidé MeSH
- metatarzální kosti * účinky léků MeSH
- potkani Sprague-Dawley MeSH
- proliferace buněk účinky léků MeSH
- růstová ploténka účinky léků metabolismus MeSH
- signální dráha Wnt účinky léků MeSH
- vývoj kostí účinky léků MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Glucocorticoids are commonly used in children with different chronic diseases. Growth failure represents a so far untreatable undesired side-effect. As lithium chloride (LiCl) is known to induce cell renewal in various tissues, we hypothesized that LiCl may prevent glucocorticoid-induced growth failure. METHODS: We monitored growth of fetal rat metatarsals cultured ex-vivo with dexamethasone and/or LiCl, while molecular mechanisms were explored through RNA sequencing by implementing the differential gene expression and gene set analysis. Quantification of β-catenin in human growth plate cartilage cultured with dexamethasone and/or LiCl was added for verification. RESULTS: After 14 days of culture, the length of dexamethasone-treated fetal rat metatarsals increased by 1.4 ± 0.2 mm compared to 2.4 ± 0.3 mm in control bones (p < 0.001). The combination of LiCl and dexamethasone led to bone length increase of 1.9 ± 0.3 mm (p < 0.001 vs. dexamethasone alone). By adding lithium, genes for cell cycle and Wnt/β-catenin, Hedgehog and Notch signaling, were upregulated compared to dexamethasone alone group. CONCLUSIONS: LiCl has the potential to partially rescue from dexamethasone-induced bone growth impairment in an ex vivo model. Transcriptomics identified cell renewal and proliferation as candidates for the underlying mechanisms. Our observations may open up the development of a new treatment strategy for bone growth disorders. IMPACT: LiCl is capable to prevent glucocorticoid-induced growth failure in rat metatarsals in vitro. The accompanying drug-induced transcriptomic changes suggested cell renewal and proliferation as candidate underlying mechanisms. Wnt/beta-catenin pathway could be one of those novel mechanisms.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25004141
- 003
- CZ-PrNML
- 005
- 20250206105949.0
- 007
- ta
- 008
- 250121s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41390-024-03192-6 $2 doi
- 035 __
- $a (PubMed)38684886
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Soucek, Ondrej $u Vera Vavrova Lab/VIAL, Department of Paediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic. ondrej.soucek@lfmotol.cuni.cz $u Paediatric Endocrinology Unit, Department of Children's and Women's Health, Karolinska Institutet, Stockholm, Sweden. ondrej.soucek@lfmotol.cuni.cz
- 245 10
- $a Lithium rescues cultured rat metatarsals from dexamethasone-induced growth failure / $c O. Soucek, O. Cinek, L. Velentza, V. Semjonov, M. Bezdicka, F. Zaman, L. Sävendahl
- 520 9_
- $a BACKGROUND: Glucocorticoids are commonly used in children with different chronic diseases. Growth failure represents a so far untreatable undesired side-effect. As lithium chloride (LiCl) is known to induce cell renewal in various tissues, we hypothesized that LiCl may prevent glucocorticoid-induced growth failure. METHODS: We monitored growth of fetal rat metatarsals cultured ex-vivo with dexamethasone and/or LiCl, while molecular mechanisms were explored through RNA sequencing by implementing the differential gene expression and gene set analysis. Quantification of β-catenin in human growth plate cartilage cultured with dexamethasone and/or LiCl was added for verification. RESULTS: After 14 days of culture, the length of dexamethasone-treated fetal rat metatarsals increased by 1.4 ± 0.2 mm compared to 2.4 ± 0.3 mm in control bones (p < 0.001). The combination of LiCl and dexamethasone led to bone length increase of 1.9 ± 0.3 mm (p < 0.001 vs. dexamethasone alone). By adding lithium, genes for cell cycle and Wnt/β-catenin, Hedgehog and Notch signaling, were upregulated compared to dexamethasone alone group. CONCLUSIONS: LiCl has the potential to partially rescue from dexamethasone-induced bone growth impairment in an ex vivo model. Transcriptomics identified cell renewal and proliferation as candidates for the underlying mechanisms. Our observations may open up the development of a new treatment strategy for bone growth disorders. IMPACT: LiCl is capable to prevent glucocorticoid-induced growth failure in rat metatarsals in vitro. The accompanying drug-induced transcriptomic changes suggested cell renewal and proliferation as candidate underlying mechanisms. Wnt/beta-catenin pathway could be one of those novel mechanisms.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a dexamethason $x farmakologie $7 D003907
- 650 12
- $a chlorid lithný $x farmakologie $7 D018021
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 12
- $a metatarzální kosti $x účinky léků $7 D008682
- 650 12
- $a beta-katenin $x metabolismus $7 D051176
- 650 _2
- $a signální dráha Wnt $x účinky léků $7 D060449
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a růstová ploténka $x účinky léků $x metabolismus $7 D006132
- 650 _2
- $a glukokortikoidy $x farmakologie $7 D005938
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a vývoj kostí $x účinky léků $7 D001846
- 650 _2
- $a potkani Sprague-Dawley $7 D017207
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Cinek, Ondrej $u Department of Paediatrics and Department of Medical Microbiology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Velentza, Lilly $u Paediatric Endocrinology Unit, Department of Children's and Women's Health, Karolinska Institutet, Stockholm, Sweden
- 700 1_
- $a Semjonov, Valerij $u Department of Paediatrics and Department of Medical Microbiology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Bezdicka, Martin $u Vera Vavrova Lab/VIAL, Department of Paediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Zaman, Farasat $u Paediatric Endocrinology Unit, Department of Children's and Women's Health, Karolinska Institutet, Stockholm, Sweden
- 700 1_
- $a Sävendahl, Lars $u Paediatric Endocrinology Unit, Department of Children's and Women's Health, Karolinska Institutet, Stockholm, Sweden $u Astrid Lindgren Children ́s Hospital, Karolinska University Hospital, Stockholm, Sweden
- 773 0_
- $w MED00003741 $t Pediatric research $x 1530-0447 $g Roč. 96, č. 4 (2024), s. 952-963
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38684886 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206105945 $b ABA008
- 999 __
- $a ok $b bmc $g 2263722 $s 1240148
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 96 $c 4 $d 952-963 $e 20240429 $i 1530-0447 $m Pediatric research $n Pediatr Res $x MED00003741
- LZP __
- $a Pubmed-20250121